Divestment10 Aug 2026, 01:24 pm
NACL Industries Executes Share Purchase Agreement for Associate Stake Sale
AI Summary
NACL Industries Limited has executed a Share Purchase Agreement (SPA) for the divestment of its equity shareholding in its associate company, Nasense Labs Private Limited. This follows the Board of Directors' approval granted on July 22, 2026, for the proposed sale. The execution of the SPA on August 10, 2026, marks a significant step in the company's strategy to divest its stake in this associate entity.
Key Highlights
- NACL Industries executed SPA for stake sale in associate Nasense Labs.
- Divestment follows Board approval granted on July 22, 2026.
- Transaction pertains to equity shareholding in the associate company.
- This is an update on the previously announced divestment plan.
Price Impact
More from NACLIND
Rights Issue27 Jul, 4:25 pm
NACL Industries Reports Nil Deviation in Rights Issue Fund Utilization
AGM/EGM23 Jul, 7:11 pm
NACL Industries Ltd: Voting Results for FY26 Financial Statements and Director Re-appointment
Divestment22 Jul, 2:06 pm
NACL Industries Sells Entire Stake in Nasense Labs for ₹8.15 Cr